Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | GBA1 | P04062 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17877990 | 0.91 | ALDH1A1 (0.64) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL10176529 | 0.88 | ALDH1A1 (0.58) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL30602365 | 0.86 | ALDH1A1 (0.63) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL12302132 | 0.76 | ALDH1A1 (0.90) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL5567042 | 0.74 | ALDH1A1 (0.75) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL18894208 | 0.74 | ALDH1A1 (1.00) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL4503066 | 0.73 | ALDH1A1 (0.74) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL27752463 | 0.73 | ALDH1A1 (0.56) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL8048430 | 0.72 | ALDH1A1 (0.96) | ALDH1A1LMNAHTTHPGDMEN1 | |
| SCHEMBL9066249 | 0.72 | ALDH1A1 (0.96) | ALDH1A1LMNAHTTHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215737-A1 | Pharmaceutical Compositions - 2 | BIOVIE INC. | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215737-A1 | Pharmaceutical Compositions - 2 | HSD3B2, HSD3B1, HSD17B2 | ALDH1A1 3156/4885LMNA 4349/4885HTT 1754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.